Fact CheckerSign in

NCT05476484Completed

Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and Asthma

Long-term Real World-effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets in Subjects With Allergic Rhinitis With or Without Asthma: Results From a Multinational, Retrospective Register Study

Source: ClinicalTrials.gov · Last updated 20 Jul 2026

Brief summary (registry, in English)

To assess the impact of SQ SLIT-tablets (SQ Grass SLIT-tablet and SQ HDM SLIT-tablet) in Danish and Swedish allergic rhinitis (AR) patients, with or without asthma, between 2007-2020.

Status (registry)
Completed
Study type
Observational
Enrollment
46196 (actual)
First submitted
29 Jun 2022
Start date
1 Apr 2022
Primary completion date
30 Jun 2024
Lead sponsor
ALK-Abelló A/S
Diseases
Asthma
NCT number
NCT05476484

What you commit to

  • Study type: Observational
  • Participants enrolled: 46196
  • From 1 Apr 2022 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • \- Any allergy immunotherapy treatment prior to the index event

Who the study is looking for

  • AR-patients identified by having at least two dispensations of prescribed AR medications for two consecutive years and/or ICD10-codes of AR in specialty care
  • For the SQ SLIT-tablet cohort:
  • \- at least 2 dispensations within 365 days of SQ SLIT-tablets (ATC: V01AA02 and V01AA03)
  • For the control cohort:
  • \- unexposed subjects will be identified from the study population of AR-patients that may be eligible to receive SQ SLIT-tablets, but have not dispensed a prescription of SQ SLIT-tablets during the index year of the case or prior to that year

Age in the registry: 5 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
ALK
Coordinator of this site? Confirm its status
HørsholmDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.